Good evening good people, As many of you here may

New Post Public Reply Private Reply Replies (1) Message Board
TSOV
779
Good evening good people,

As many of you here may recall, I am a longtime reader/follower/aficionado/investor of this site and CYDY.

The price action this week was particularly amusing.
The week began at $2.45, visited the $2.30s on Tuesday, the $2.20s on Wednesday, the high teens on Thursday and capitulated its teen status as of this afternoon's closing print, at $2.12. The humor of these closing prints for someone like me (given my line of work) is beyond humorous. I think the term the kids nowadays use is 'tryhard'. The job has been done. The closing mark for the last full week of March is at the closing low for the entire month. Those who are short will receive a magnificent mark to market from their clearing firms and will have wonderful request for funds met with a maximum credit available from their account (golf clap). Next Mon/Tues/Wed will be quite dramatic. IF Nader is to be believed, we will be post 2 full weeks for a conditional EUA request to THEE FDA.

Time is a very funny thing, as it passes the hard facts of life stay fixed, and what appeared initially to be mutable tends to become either dismissed wholly or proven immutable. My favorite historical examples of this phenomena being a. Gravity, b. Relativity, c. Quantum Mechanics (some of the more scientific leaning readers here might observe my form of humor). Smooth versus lumpy seems to be the ride most investors prefer. Unfortunately, the market is rarely this kind. However, it could be worse. Really.

Imagine if you will that you are THEE FDA. The world is afflicted with a global pandemic. You, the arbiter of all things cutting edge medical science and establishment are tasked with stanching the pandemic as it afflicts the most technological advanced country that has ever existed, which also happens to be the only global superpower left after a decades long cold war. Fifty six weeks in all you have to show to the world is the world's leading death and infection count and 3 vaccines of which no one is quite sure of their longterm side effects nor efficacy in treating or preventing S/C COVID-19 appearing within new variants that are popping up with a frequency that make the game of Whack-A-Mole seem tame. You have granted EUA status to 5 biologic drugs within the past 56 weeks. At week 57 you face the hard cold reality that 3 of the 5 have failed to produce ANY life saving benefit. To make matters worse, 2 of the products granted EUA status have been revoked. As you approach week 58 you quietly release the following:

*** The US government and Eli Lilly agreed to halt all distribution of the company’s Covid-19 monoclonal antibody bamlanivimab as of Wednesday due to the “sustained increase” of coronavirus variants in the US.

All treatment delivery sites will continue to be able to order Lilly’s combo Covid-19 treatment of bamlanivimab and etesevimab, to be administered together, or Regeneron’s antibody cocktail, the assistant secretary for preparedness and response (ASPR) and FDA said. Both of the treatments from Lilly and Regeneron have proven to be useful among people who have Covid-19 but are not hospitalized.

“We recognize the U.S. government has made the decision to no longer allow direct ordering of bamlanivimab alone due to concerns about the prevalence of the California (B.1.427/B.1.429) and New York (B.1.526) variants of SARS-CoV-2. The U.S. government has enabled direct ordering of bamlanivimab and etesevimab together as well as etesevimab alone, to pair with bamlanivimab that sites of care have on hand,” Lilly said in an emailed statement.
*** ENPOINTS NEWS 3/25/21 10:14AM EDT

(all while simultaneously trumpeting yet a "new" MAB from this stellar BP within the 24hr news cycle)

All as we get reports such as https://abcnews.go.com/US/variants-account-51...d=76367582

Meanwhile, here in the cheaper-by-the-day seats, we sit with a biologic drug proven safe, near 30% efficacious in treating S/C COVID-19 patients over SOC that is "variant agnostic". Oh yes, Miami Beach closed the causeways and instituted a forced curfew for its unmasked spring breakers when we were at $2.45. Who knew?!?!

Good people, we may be short on upticks but we certainly are not short on THEE FDA induced maudlin humor.

Bon chance,
TSOV
2

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 530

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 145

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 271

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 518

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 206

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 175

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 630

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 0

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 777

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
Boston STEM Expo Sparks Young Minds in Engineering

Updated Category News Views 281

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

Continue Reading

Top 5 Most Recently Viewed Articles

Fabuwood Unveils Mocha: A Sophisticated Stain for Modern Cabinets

Updated Category News Views 377

Fabuwood Introduces Mocha: A New Era in Cabinet Stains Fabuwood has delighted the home improvement community with the launch of their newest cabinet stain, Mocha. This inviting, versatile color showcases a beautiful balance of warmth and sophistication. As a highly anticipated addition, Mocha complements the existing range of popular natural stains from Fabuwood,...

Continue Reading
Revolutionizing Home Lighting with AI Technology by Lepro

Updated Category News Views 266

Revolutionizing Home Lighting with AI Technology Lepro, a pioneering company in AI lighting innovation, has introduced an incredible advancement at the Consumer Electronics Show (CES) 2025. The innovative product, LightGPM 3, is designed as an artificial intelligence-driven lighting design assistant that makes professional lighting accessible to everyone. LightGPM 3: Your...

Continue Reading
Insights on Upcoming Bond Listing by Jyske Realkredit A/S

Updated Category News Views 135

Understanding the Bond Listing by Jyske Realkredit A/S On September 5, 2025, an important announcement was issued regarding the final terms for a new bond issuance by Jyske Realkredit A/S aimed at the market, set to be listed soon. Details of the Upcoming Bond Offering This bond, categorized as a Covered Bond (SDO), aims to officially open for transaction on February 10,...

Continue Reading
Smart Meter Market Set for $23.46B Leap by 2031

Updated Category News Views 8

Smart Meters: Electrifying Market Growth Ahead In the fast-evolving world of utilities, the smart electricity meter market is gearing up for a substantial leap, jumping from USD 15.02 billion in 2026 to a remarkable USD 23.46 billion by 2031. A recent study from Mordor Intelligence shines a light on this trajectory, emphasizing a robust compound annual growth rate (CAGR)...

Continue Reading
Bitcoin Struggles to Maintain $100k Amid Fed's Rate Concerns

Updated Category News Views 109

Bitcoin's Recent Price Movements Recently, Bitcoin has experienced notable fluctuations, trading at approximately $95,445.4, following a week filled with substantial declines. Market participants are now more skeptical, assessing the macroeconomic landscape shaped by the Federal Reserve's comments. The Impact of Fed's Hawkish Stance The Federal Reserve's recent...

Continue Reading